2 Apr 2020
Experts from the Universities of Birmingham and Oxford have joined the National Rheumatoid Arthritis Society (NRAS) in reaching out to Asian people living with inflammatory forms of arthritis (IA) (in particular, Rheumatoid Arthritis (RA)) with information on how to keep themselves and their families safe from coronavirus.
RA news | 13 Mar 2020
We understand that many people with RA or JIA and their families may be concerned at the Coronavirus pandemic described by the World Health Organisation as ‘a global public health emergency’.
RA news | 10 Mar 2020
The European League Against Rheumatism (EULAR) have issued updated guidelines on the management of RA, which had previously been updated in 2016.
RA news | 23 Jan 2020
For some time, NRAS has been concerned that some Clinical Commissioning Groups (CCGs) have been artificially restricting access to advanced therapies (biologics, biosimilars/JAK inhibitors) and undertook a Freedom of Information request to all CCGs about this.
NRAS News | 4 Nov 2019
On 1st November, NRAS held its 6th Healthcare Champion awards ceremony in the magnificent surroundings of the Leathersellers’ Livery Hall in London.
NRAS News | 11 Oct 2019
'My Arthritis' empowers patients with timely, relevant information and is designed to improve quality of life and outcomes.
RA news | 11 Oct 2019
A new report reveals that patients with suspected early inflammatory arthritis are waiting too long to see a specialist.
Shaping the Rheumatology Service in Scotland Scottish Quality Registry (ScotQR) for Rheumatoid ArthritisRA news | 11 Oct 2019
People with RA will be interested to know about a new initiative very soon to be trialled in two areas of Scotland, NHS Greater Glasgow and Clyde and NHS Lanarkshire.
NRAS News | 10 Oct 2019
A leading rheumatoid arthritis charity is warning that treatment delays for patients with suspected early inflammatory arthritis could result in unnecessary harm. National Rheumatoid Arthritis Society (NRAS) said that thousands of people who potentially have the condition aren’t getting treatment in line with NICE guidelines and Quality Standards, which risks life-long disabilities.